Blend Therapeutics Obtains $999,999 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=505fec88-54d7-4009-ac43-2be9ddc47f3a
Date
3/12/2014
Company Name
Blend Therapeutics
Mailing Address
134 Coolidge Avenue Watertown, MA 02472
Company Description
Blend is pioneering controlled combination medicines that overcome the limitations of conventional combination therapy through their unprecedented ability to hit distinct disease pathways with multiple drugs in concert—at the desired sites, at the most effective concentrations, and for the right durations—to drive optimal effects from each drug on the disease process.
Website
http://www.blendtx.com
Transaction Type
Venture Equity
Transaction Amount
$999,999
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Undisclosed